FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Issue Open | May 21, 2024 |
Issue Close | May 31, 2024 |
Issue Size (Shares) | 8.76 Crores |
Issue Size (Amount) | ₹43.81 Crores |
Issue Price | ₹5 per Share |
Listing At | NSE |
July 1, 2024 1:05:00 PM
Ajooni Biotech, a pure vegetarian animal healthcare solutions provider, has secured an Rs 4.95 crore order from a major Indian dairy supplier. This significant order adds to their expanding export ...
Published by : devdiscourseJune 2, 2024 10:01:00 AM
Ajooni Biotech Limited has unveiled its plans for commercial production of Moringa by financial year 2025-26. This significant development aligns with the company's ongoing rights-issue and the ...
Published by : MSNJune 28, 2024 3:30:00 AM
Ajooni Biotech Ltd share price was up by 4.99% from the previous closing price of ?5.01. Who are peers of Ajooni Biotech Ltd? The peers of Ajooni Biotech Ltd are Hindustan Unilever Ltd ...
Published by : Business TodayJune 28, 2024 3:30:00 AM
Unlike many unprofitable biotech companies, Regeneron was in the �green� and generated $4.3 billion in net income in 2022. Eylea could be vulnerable to biosimilars competition starting in 2024.
Published by : USA TodayJune 13, 2024 7:41:00 PM
In FY24, NABARD secured the highest mobilisation through debt private placements at Rs 51,855 crore closely followed by REC and HDFC The company's rights issue will open on March 6 for the ...
Published by : moneycontrol.comJuly 1, 2024 3:30:00 AM
Looking for the best biotech penny stocks ... U.S. for small business inclusivity and intellectual property rights. Many of the issues they address directly affect small-cap and penny stocks ...
Published by : Benzinga.comJune 7, 2024 3:31:00 AM
Investing in biotechnology stocks has always required ... In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump ...
Published by : MorningstarJune 25, 2024 3:30:00 AM
Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
Published by : NatureJune 25, 2024 3:30:00 AM
and transgender peoples' rights, and with activists representing a multiplicity of identities and issues. We document and expose abuses based on sexual orientation and gender identity worldwide ...
Published by : Human Rights WatchJune 6, 2024 12:52:00 PM
Biotech firms produce meds from organisms; pharma companies create drugs chemically. Biotechs file a BLA for FDA approval, while pharmas submit an NDA. Investors should assess management, market ...
Published by : The Motley FoolJune 2, 2024 5:37:00 PM
It�s the preeminent civil rights issue of our day: the protection of girls in women�s sports. Last month�s stolen victory by a male runner in the girls� 400-meter dash at the Washington ...
Published by : New York PostJune 3, 2024 4:08:00 PM
Commissions do not affect our editors' opinions or evaluations. Biotech stocks are not for the faint of heart. These highly volatile equities can see stomach-churning price swings, driven by how ...
Published by : ForbesRead Ajooni Biotech Rights Issue 2024 current news. Find Ajooni Biotech Rights Issue 2024 subscription news, Rights Issue analysis, broker reviews, allotment news, and listing date. Get the Ajooni Biotech Limited Rights Issue grey market premium and Ajooni Biotech Rights Issue 2024 expected listing price.
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|